Literature DB >> 17917005

Acquired immunologic tolerance: with particular reference to transplantation.

Thomas E Starzl1.   

Abstract

The first unequivocally successful bone marrow cell transplantation in humans was recorded in 1968 by the University of Minnesota team of Robert A. Good (Gatti et al. Lancet 2: 1366-1369, 1968). This achievement was a direct extension of mouse models of acquired immunologic tolerance that were established 15 years earlier. In contrast, organ (i.e. kidney) transplantation was accomplished precociously in humans (in 1959) before demonstrating its feasibility in any experimental model and in the absence of a defensible immunologic rationale. Due to the striking differences between the outcomes with the two kinds of procedure, the mechanisms of organ engraftment were long thought to differ from the leukocyte chimerism-associated ones of bone marrow transplantation. This and other concepts of alloengraftment and acquired tolerance have changed over time. Current concepts and their clinical implications can be understood and discussed best from the perspective provided by the life and times of Bob Good.

Entities:  

Mesh:

Year:  2007        PMID: 17917005      PMCID: PMC2800371          DOI: 10.1007/s12026-007-0001-7

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  99 in total

1.  Organ transplantation: a practical triumph and epistemologic collapse.

Authors:  Thomas E Starzl
Journal:  Proc Am Philos Soc       Date:  2003-09

2.  Donor dendritic cell repopulation in recipients after rat-to-mouse bone-marrow transplantation.

Authors:  C Ricordi; S T Ildstad; A J Demetris; A Y Abou el-Ezz; N Murase; T E Starzl
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

3.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

4.  Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.

Authors:  S Webb; C Morris; J Sprent
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

5.  Orthotopic homotransplantation of the human liver.

Authors:  T E Starzl; C G Groth; L Brettschneider; I Penn; V A Fulginiti; J B Moon; H Blanchard; A J Martin; K A Porter
Journal:  Ann Surg       Date:  1968-09       Impact factor: 12.969

6.  A biological role for the major histocompatibility antigens.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Lancet       Date:  1975-06-28       Impact factor: 79.321

7.  Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation.

Authors:  Ron Shapiro; Demetrius Ellis; Henkie P Tan; Michael L Moritz; Amit Basu; Abhay N Vats; Akhtar S Khan; Edward A Gray; Adrianna Zeevi; Corde McFeaters; Gerri James; Mary Jo Grosso; Amadeo Marcos; Thomas E Starzl
Journal:  J Pediatr       Date:  2006-06       Impact factor: 4.406

8.  Homologous human kidney transplantation. Experience with six patients.

Authors:  R KUSS; M LEGRAIN; G MATHE; R NEDEY; M CAMEY
Journal:  Postgrad Med J       Date:  1962-09       Impact factor: 2.401

9.  Redistribution of renal allograft-responding leukocytes during rejection. II. Kinetics and specificity.

Authors:  A Nemlander; A Soots; E von Willebrand; B Husberg; P Hayry
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection.

Authors:  C P Larsen; P J Morris; J M Austyn
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  8 in total

1.  Immunosuppressive therapy and tolerance of organ allografts.

Authors:  Thomas E Starzl
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

2.  Anthony Cerami Award in Translational Medicine: A Journey in Science: The Birth of Organ Transplantation with Particular Reference to Alloengraftment Mechanisms.

Authors:  Thomas E Starzl
Journal:  Mol Med       Date:  2015-06-25       Impact factor: 6.354

3.  Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes.

Authors:  Ngoc L Thai; Akhtar Khan; Kusum Tom; Deanna Blisard; Amit Basu; Henkie P Tan; Amadeo Marcos; John J Fung; Thomas E Starzl; Ron Shapiro
Journal:  Transplantation       Date:  2006-12-27       Impact factor: 4.939

4.  Donor-derived peripheral mononuclear cell DNA is associated with stable kidney allograft function: a randomized controlled trial.

Authors:  Ghasem Solgi; Joannis Mytilineos; Vijayakrishna Gadi; Biswajit Paul; Gholamreza Pourmand; Abdolrasoul Mehrsai; Behrouz Nikbin; Ali Akbar Amirzargar
Journal:  Chimerism       Date:  2011 Oct-Dec

5.  A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab.

Authors:  Gaetano Ciancio; Junichiro Sageshima; Edip Akpinar; Jeffrey J Gaynor; Linda Chen; Alberto Zarak; Lois Hanson; Lissett Tueros; Giselle Guerra; Adela Mattiazzi; Warren Kupin; David Roth; Camillo Ricordi; George W Burke
Journal:  Transplantation       Date:  2013-11-15       Impact factor: 4.939

6.  Complications of right lobe living donor liver transplantation.

Authors:  James W Marsh; Edward Gray; Roberta Ness; Thomas E Starzl
Journal:  J Hepatol       Date:  2009-05-27       Impact factor: 25.083

7.  Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression.

Authors:  Stefan Schneeberger; Vijay S Gorantla; Gerald Brandacher; Adriana Zeevi; Anthony J Demetris; John G Lunz; Diana M Metes; Albert D Donnenberg; Jaimie T Shores; Andrea F Dimartini; Joseph E Kiss; Joseph E Imbriglia; Kodi Azari; Robert J Goitz; Ernest K Manders; Vu T Nguyen; Damon S Cooney; Galen S Wachtman; Jonathan D Keith; Derek R Fletcher; Camila Macedo; Raymond Planinsic; Joseph E Losee; Ron Shapiro; Thomas E Starzl; W P Andrew Lee
Journal:  Ann Surg       Date:  2013-02       Impact factor: 12.969

8.  Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival.

Authors:  Ghasem Solgi; Vijayakrishna Gadi; Biswajit Paul; Joannis Mytilineos; Gholamreza Pourmand; Abdolrasoul Mehrsai; Moslem Ranjbar; Mousa Mohammadnia; Behrouz Nikbin; Ali Akbar Amirzargar
Journal:  Chimerism       Date:  2013-05-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.